COMMUNIQUÉS West-GlobeNewswire

Active Biotech AB: Interim report January – June 2019
08/08/2019
Significant events during the second quarter In accordance with the Board’s proposal, the Extraordinary General Meeting on April 4, 2019, resolved to approve the sale of the company’s property to Estea AB Active Biotech [...]
Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing
08/08/2019
Initial focus on non-diagnostic testing with Next Generation Sequencing (NGS) for infection control, outbreak management and research First commercial orders received and processed Vienna, Austria, and Holzgerlingen, [...]
Change to the Executive Leadership Team
08/08/2019
Please read the full announcement in PDF Attachment 2019_28_Change_to_the_Executive_Leadership_Team_EN
Interim report for the first half of 2019
08/08/2019
Read the full announcement in PDF Attachment 2019_27_Q22019_CompanyAnnouncement_FINAL_EN
Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
08/08/2019
Source: Mesa Laboratories, Inc. – August 7, 2019 11:20 PM ET Lakewood, Colo., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the pricing of concurrent underwritten [...]
Telix Pharmaceuticals and GenesisCare Commence ENHANCING Prostate Cancer Clinical Study
08/08/2019
MELBOURNE, Australia and SYDNEY, Australia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted [...]
Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial
08/08/2019
RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
MyDx Announces Letter to Shareholders
08/08/2019
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MyDx, Inc. ( OTC: MYDX ), a leader in science based cannabis health technologies, today issued a press release with the following letter to shareholders. [...]
New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRA® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome
07/08/2019
Mean triglyceride levels decreased 77% in volanesorsen-treated patients versus an 18% increase in patients in placebo group Akcea launching WAYLIVRA in the European Union BOSTON and CARLSBAD, Calif, Aug. 07, 2019 (GLOBE [...]
LHC Group Announces Second Quarter 2019 Financial Results
07/08/2019
Strong Execution on Organic Growth and M&A Strategy Affirms 2019 Guidance LAFAYETTE, La., Aug. 07, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced its financial results for the quarter ended June [...]
Jean-Denis Talon Retires From Theratechnologies’ Board of Directors
07/08/2019
MONTREAL, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that Mr. Jean-Denis Talon has decided to retire from the board of directors of Theratechnologies. He was [...]
Jean-Denis Talon quitte le conseil d’administration de Theratechnologies
07/08/2019
MONTRÉAL, 07 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) a annoncé aujourd’hui que M. Jean-Denis Talon a décidé de quitter le conseil d’administration de Theratechnologies. Il [...]
Atrion Reports Second Quarter Results
07/08/2019
ALLEN, Texas, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2019 revenues totaled $40.1 million compared with $38.8 million for the same [...]
OrthoPediatrics Corp. Reports Second Quarter 2019 Financial Results
07/08/2019
Record revenue of $18.2 Million, Up 20.7% Year-over-Year WARSAW, Ind., Aug. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of [...]
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
07/08/2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) , a commercial -stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology [...]
Catalyst Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update
07/08/2019
Firdapse ® Launch Momentum Continues with Second Quarter Net Revenues of $28.8 Million 409 Adult LEMS Patients Active on Firdapse as of June 30, 2019 Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow [...]
Y-mAbs to Announce Second Quarter 2019 Financial and Operating Results on August 14
07/08/2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its second quarter 2019 financial and operating results on Wednesday, [...]
The Cooper Companies to Participate in the Wells Fargo Securities Healthcare Conference
07/08/2019
PLEASANTON, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the 2019 Wells Fargo Securities Healthcare Conference in Boston, MA, on September 5, 2019. Albert G. White [...]
Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock
07/08/2019
EMERYVILLE, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines, [...]

Pages